CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickey, R.
Right arrow Articles by Ramamurthy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickey, R.
Right arrow Articles by Ramamurthy, S.

Canadian Journal of Anesthesia, Vol 37, 878-882, Copyright © 1990 by Canadian Anesthesiologists' Society

ARTICLES

Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block

R Hickey, J Blanchard, J Hoffman, J Sjovall and S Ramamurthy
Department of Anesthesiology, University of Texas Health Science Center, San Antonio 78284.

The purpose of this study was to determine the pharmacokinetic properties of the local anaesthetic ropivacaine used with or without epinephrine for brachial plexus block. Seventeen ASA physical status I or II adult patients undergoing elective orthopaedic surgery received a single injection of 33 ml ropivacaine for subclavian perivascular block and 5 ml to block the intercostobrachial nerve in the axilla. One group (n = 8) received 0.5 per cent ropivacaine without epinephrine (190 mg) and the other (n = 9) received 0.5 per cent ropivacaine with epinephrine 1:200,000 (190 mg). Plasma ropivacaine concentrations were measured from peripheral venous blood samples taken for 12 hr after drug administration. Ropivacaine base was determined in plasma using gas chromatography and a nitrogen-sensitive detector. The mean peak plasma concentration (Cmax) was 1.6 +/- 0.6 mg.L-1 and 1.3 +/- 0.4 mg.L-1 after administration of ropivacaine with and without epinephrine. The median time to peak plasma concentration (tmax) was 0.75 hr and 0.88 hr and the mean area under the plasma concentration curve AUC0-12h was 7.7 +/- 3.6 and 7.0 +/- 3.4 mg.l hr-1. The differences were not statistically significant. The terminal phase of the individual plasma concentration-time curves showed a varying and sometimes slow decline possibly indicating a sustained systemic uptake of ropivacaine from the brachial plexus. No central nervous system or cardiovascular symptoms attributed to systemic plasma concentrations of the drug were observed, with the dose (1.90-3.28 mg.kg-1) of ropivacaine used. It is concluded that the addition of epinephrine does not alter the pharmacokinetic properties of ropivacaine when used for subclavian perivascular brachial plexus block.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
B. T. Finucane
Ropivacaine cardiac toxicity - not as troublesome as bupivacaine/La toxicite cardiaque a la ropivacaine, comparee a la bupivacaine, ne presente pas autant de complications
Can J Anesth, May 1, 2005; 52(5): 449 - 453.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
B. B. Lee, W. D. Ngan Kee, J. L. Plummer, M. K. Karmakar, and A. S.Y. Wong
The Effect of the Addition of Epinephrine on Early Systemic Absorption of Epidural Ropivacaine in Humans
Anesth. Analg., November 1, 2002; 95(5): 1402 - 1407.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J.-P. Estebe, P. Le Corre, L. Du Plessis, F. Chevanne, G. Cathelineau, R. Le Verge, and C. Ecoffey
The Pharmacokinetics and Pharmacodynamics of Bupivacaine-Loaded Microspheres on a Brachial Plexus Block Model in Sheep
Anesth. Analg., August 1, 2001; 93(2): 447 - 455.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. B. Whiteside and J. A. W. Wildsmith
Developments in local anaesthetic drugs
Br. J. Anaesth., July 1, 2001; 87(1): 27 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. R. M. Janzen, A. J. Vipond, D. J. Bush, and P. M. Hopkins
A Comparison of 1% Prilocaine with 0.5% Ropivacaine for Outpatient-Based Surgery Under Axillary Brachial Plexus Block
Anesth. Analg., July 1, 2001; 93(1): 187 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
G. Ekatodramis, A. Borgeat, C. Mardirosoff, and L. Dumont
Convulsions after the administration of high dose ropivacaine following an interscalenic block
Can J Anesth, June 1, 2001; 48(6): 613 - 614.
[Full Text]

Home page
 Br J AnaesthHome page
C. Connolly, D. M. Coventry, and J. A. W. Wildsmith
Double-blind comparison of ropivacaine 7.5 mg ml-1 with bupivacaine 5 mg ml-1 for sciatic nerve block
Br. J. Anaesth., May 1, 2001; 86(5): 674 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
C Mardirosoff and L Dumont
Convulsions after the administration of high dose ropivacaine following an interscalenic block
Can J Anesth, December 1, 2000; 47(12): 1263 - 1263.


Home page
 Canadian J. AnesthesiaHome page
A. H. El Saied, M. P. Steyn, and J. M. Ansermino
Clonidine prolongs the effect of ropivacaine for axillary brachial plexus blockade
Can J Anesth, October 1, 2000; 47(10): 962 - 967.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
H. Wulf, F. Worthmann, H. Behnke, and A. S. Bohle
Pharmacokinetics and Pharmacodynamics of Ropivacaine 2 mg/mL, 5 mg/mL, or 7.5 mg/mL After Ilioinguinal Blockade for Inguinal Hernia Repair in Adults
Anesth. Analg., December 1, 1999; 89(6): 1471 - 1471.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Canadian Anesthesiologists' Society.